
|Articles|September 25, 2015
Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/colon-cancer-multiple-myeloma-drug-development-hig" target="_blank">View the story "Colon Cancer, Multiple Myeloma Drug Development Highlights Week in Specialty Pharmacy" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
4
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
5




























































































































